Jun 10, 2024
by Amy Lee
Investor Insights: Digital Healthcare Industry Analysis
Hello,
In this week’s update, we take a deep dive into the fast-growing digital healthcare sector, exploring key trends, major players, and investment opportunities shaping the future of medical technology.
The Digital Healthcare Landscape
Digital healthcare is revolutionizing the medical industry, integrating technology and data-driven solutions to improve patient care, streamline operations, and enhance disease management.
Key areas of growth include:
Mobile Health (57%) – Smartphone apps for health monitoring and management.
Digital Health Systems (29%) – Electronic health records (EHR) and hospital IT infrastructure.
Healthcare Analytics (10%) – Medical data insights driving better decision-making.
Telemedicine (4%) – Remote consultations and virtual healthcare services.
The global digital healthcare market is on a strong growth trajectory, projected to expand at an annual rate of 18.8%, jumping from $152.5 billion (KRW 198 trillion) in 2020 to $508.8 billion (KRW 661 trillion) by 2027.
Several factors are fueling this momentum, including aging populations, the rise of chronic diseases (such as cancer, diabetes, and hypertension), and increased adoption of cloud-based healthcare and genetic analysis technologies.
For investors, this sector presents significant opportunities, particularly in medical AI, healthcare IT, and precision medicine.
Featured Companies: Lunit and Deepnoid
Lunit (KRX: 328130) – Advancing Cancer Diagnostics
Lunit is at the forefront of cancer detection and treatment innovation, using AI-driven imaging solutions to improve accuracy and efficiency.
Key solutions:
Lunit INSIGHT – AI-powered detection for chest X-rays and mammography, enhancing early cancer diagnosis.
Lunit SCOPE – Imaging biomarker solutions for personalized cancer treatment.
Lunit’s recent acquisition of Volpara Health Technologies, a U.S. leader in breast cancer screening (42% market share), significantly expands its footprint in the American market. Additionally, with the launch of Lunit Europe Holdings and partnerships with firms like Radiobotics (Denmark), the company is strategically positioning itself for global expansion.
Deepnoid (KRX: 315640) – AI-Powered Medical Imaging
Deepnoid specializes in AI-driven diagnostic tools, improving speed and accuracy in medical imaging analysis.
Key solutions:
DEEP NEURO – AI-assisted brain MRA imaging for faster, more precise neurological diagnoses.
DEEP CHEST – AI-driven chest X-ray analysis for respiratory condition detection.
DEEP LUNG – AI-powered low-dose CT interpretation for early lung cancer detection.
Deepnoid also offers DEEP PHI, a no-code AI development platform enabling healthcare professionals to create their own AI-powered tools. Beyond healthcare, the company is expanding into AI applications for secondary batteries, displays, and other industries.
Industry Challenges & Outlook
While digital healthcare presents vast opportunities, challenges remain—regulatory hurdles, market trust issues, and short-term investor concerns over financial performance.
However, with economic recovery, improving company fundamentals, and anticipated regulatory reforms, the digital healthcare sector—particularly in medical AI—is expected to gain traction and deliver long-term value.
Key Takeaways for Investors
The digital healthcare market is set to grow at 18.8% annually through 2027, driven by aging populations and rising chronic diseases.
Medical AI, cloud-based healthcare systems, and genomic analytics are poised for significant expansion.
Lunit and Deepnoid stand out as leading innovators, offering cutting-edge solutions in cancer diagnostics and medical imaging.
Thank you for your continued trust in Laplace Partners. We’ll be back with more insights in our next update.
Warm regards,
The Laplace Partners Team
This version keeps it professional, engaging, and investor-focused while making it more readable and humanized. Let me know if you’d like any further refinements! 🚀
The Digital Healthcare Landscape
Digital healthcare is revolutionizing the medical industry, integrating technology and data-driven solutions to improve patient care, streamline operations, and enhance disease management.
Key areas of growth include:
Mobile Health (57%) – Smartphone apps for health monitoring and management.
Digital Health Systems (29%) – Electronic health records (EHR) and hospital IT infrastructure.
Healthcare Analytics (10%) – Medical data insights driving better decision-making.
Telemedicine (4%) – Remote consultations and virtual healthcare services.
The global digital healthcare market is on a strong growth trajectory, projected to expand at an annual rate of 18.8%, jumping from $152.5 billion (KRW 198 trillion) in 2020 to $508.8 billion (KRW 661 trillion) by 2027.
Several factors are fueling this momentum, including aging populations, the rise of chronic diseases (such as cancer, diabetes, and hypertension), and increased adoption of cloud-based healthcare and genetic analysis technologies.
For investors, this sector presents significant opportunities, particularly in medical AI, healthcare IT, and precision medicine.
Featured Companies: Lunit and Deepnoid
Lunit (KRX: 328130) – Advancing Cancer Diagnostics
Lunit is at the forefront of cancer detection and treatment innovation, using AI-driven imaging solutions to improve accuracy and efficiency.
Key solutions:
Lunit INSIGHT – AI-powered detection for chest X-rays and mammography, enhancing early cancer diagnosis.
Lunit SCOPE – Imaging biomarker solutions for personalized cancer treatment.
Lunit’s recent acquisition of Volpara Health Technologies, a U.S. leader in breast cancer screening (42% market share), significantly expands its footprint in the American market. Additionally, with the launch of Lunit Europe Holdings and partnerships with firms like Radiobotics (Denmark), the company is strategically positioning itself for global expansion.
Deepnoid (KRX: 315640) – AI-Powered Medical Imaging
Deepnoid specializes in AI-driven diagnostic tools, improving speed and accuracy in medical imaging analysis.
Key solutions:
DEEP NEURO – AI-assisted brain MRA imaging for faster, more precise neurological diagnoses.
DEEP CHEST – AI-driven chest X-ray analysis for respiratory condition detection.
DEEP LUNG – AI-powered low-dose CT interpretation for early lung cancer detection.
Deepnoid also offers DEEP PHI, a no-code AI development platform enabling healthcare professionals to create their own AI-powered tools. Beyond healthcare, the company is expanding into AI applications for secondary batteries, displays, and other industries.
Industry Challenges & Outlook
While digital healthcare presents vast opportunities, challenges remain—regulatory hurdles, market trust issues, and short-term investor concerns over financial performance.
However, with economic recovery, improving company fundamentals, and anticipated regulatory reforms, the digital healthcare sector—particularly in medical AI—is expected to gain traction and deliver long-term value.
Key Takeaways for Investors
The digital healthcare market is set to grow at 18.8% annually through 2027, driven by aging populations and rising chronic diseases.
Medical AI, cloud-based healthcare systems, and genomic analytics are poised for significant expansion.
Lunit and Deepnoid stand out as leading innovators, offering cutting-edge solutions in cancer diagnostics and medical imaging.
Thank you for your continued trust in Laplace Partners. We’ll be back with more insights in our next update.
Warm regards,
The Laplace Partners Team
Back to News